{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T04:29:06Z","timestamp":1687408146345},"reference-count":31,"publisher":"ARAN Ediciones","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutr Hosp"],"published-print":{"date-parts":[[2023]]},"DOI":"10.20960\/nh.04646","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T11:36:00Z","timestamp":1687347360000},"source":"Crossref","is-referenced-by-count":0,"title":["Review of real-life teduglutide experience"],"prefix":"10.20960","author":[{"given":"Jos\u00e9 A.","family":"Irles-Rocamora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Campos Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Tejera P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Virgili Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8588","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.20960\/nh.400"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.22585\/hospdomic.v6i1.152"},{"key":"ref3","unstructured":"Seisdedos Elcuaz R, Mej\u00edas Trueba M, Rodr\u00edguez Ramallo H, P\u00e9rez Blanco JL, Pereira Cunill JL, Garc\u00eda Luna PP. Evoluci\u00f3n de los pacientes con nutrici\u00f3n parenteral domiciliaria: una revisi\u00f3n sistem\u00e1tica de los estudios disponibles [Evolution of patients with home parenteral nutrition: a systematic review of available studies]. Nutr Hosp. 2020 Jul 13;34(3):599-608"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.09.007"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2015.69"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.10092"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/nu14040796"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Raghu VK, Binion DG, Smith KJ. Cost-effectiveness of teduglutide in adult patients with short bowel syndrome: Markov modeling using traditional cost-effectiveness criteria. Am J Clin Nutr. 2020 Jan 1;111(1):141\u20138.","DOI":"10.1093\/ajcn\/nqz269"},{"key":"ref9","unstructured":"National Institute for Health and Care Excellence,.Appraisal consultation document \u2013 teduglutide for treating short bowel syndrome March 2022 , Internet . (Acceso abril 2023) https:\/\/www.nice.org.uk\/guidance\/ta804\/documents\/129"},{"key":"ref10","unstructured":"Alfaro Mart\u00ednez JJ , \u00c1lvarez de Frutos V .C\u00e1novas Gaillem\u00edn B, Encinas Barrios C , Fraga Fuentes MD, Garc\u00eda Manzanares A, et al Documento de Consenso: Teduglutida en el tratamiento del s\u00edndrome de intestino corto. Octubre de 2018. Grupo de trabajo SESCAM para documento de consenso de Teduglutida, Internet. (Acceso Abril 2023).https:\/\/sanidad.castillalamancha.es\/sites\/sescam.castillalamancha.es\/files\/documentos\/farmacia\/5.documento_de_consenso_sescam_teduglutida_2018.pdf"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Pape UF, Iyer KR, Jeppesen PB, Kunecki M, Pironi L, Schneider SM, Seidner DL, Lee HM, Caminis J. Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials. Therap Adv Gastroenterol. 2020 Apr 20;13:1756284820905766","DOI":"10.1177\/1756284820905766"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Pevny S, Maasberg S, Rieger A, Karber M, Bl\u00fcthner E, Knappe-Drzikova B, Thurmann D, B\u00fcttner J, Weylandt KH, Wiedenmann B, M\u00fcller VA, Bl\u00e4ker H, Pascher A, Pape UF. Experience with teduglutide treatment for short bowel syndrome in clinical practice. Clin Nutr. 2019 Aug;38(4):1745-1755","DOI":"10.1016\/j.clnu.2018.07.030"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Schoeler M, Klag T, Wendler J, Bernhard S, Adolph M, Kirschniak A, et al. GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting. Ther Adv Gastroenterol [Internet]. 2018 Aug 30 [cited 2022 May 13];11:1756284818793343.","DOI":"10.1177\/1756284818793343"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Joly F, Seguy D, Nuzzo A, Chambrier C, Beau P, Poullenot F, et al. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study. Clin Nutr Edinb Scotl. 2020 Sep;39(9):2856\u201362.","DOI":"10.1016\/j.clnu.2019.12.019"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Puello F, Wall E, Herlitz J, Lozano ES, Semrad C, Micic D. Long-Term Outcomes With Teduglutide From a Single Center. JPEN J Parenter Enteral Nutr. 2021 Feb;45(2):318\u201322.","DOI":"10.1002\/jpen.1838"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Solar H, Doeyo M, Ortega M, De Barrio S, Olano E, Moreira E, et al. Postsurgical Intestinal Rehabilitation Using Semisynthetic Glucagon-Like Peptide-2 Analogue (sGLP-2) at a Referral Center: Can Patients Achieve Parenteral Nutrition and sGLP-2 Independency? JPEN J Parenter Enteral Nutr. 2021 Jul;45(5):1072\u201382.","DOI":"10.1002\/jpen.1983"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Loutfy A, Kurin M, Shah R, Davitkov P. Characterization of American teduglutide consumers from 2015 to 2020: A large database study. J Parenter Enteral Nutr. 2022; 46:646-651.","DOI":"10.1002\/jpen.2221"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Greif S, Maasberg S, Wehkamp J, Fusco S, Zopf Y, Herrmann HJ, et al . Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program. Clin Nutr ESPEN. 2022 Oct;51:222-230.","DOI":"10.1016\/j.clnesp.2022.08.027"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Hill S, Carter BA, Cohran V, Horslen S, Kaufman SS, Kocoshis SA, et al. Safety Findings in Pediatric Patients During Long-Term Treatment With Teduglutide for Short-Bowel Syndrome-Associated Intestinal Failure: Pooled Analysis of 4 Clinical Studies. JPEN J Parenter Enteral Nutr. 2021 Sep;45(7):1456\u201365.","DOI":"10.1002\/jpen.2061"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ramos Boluda E, Redecillas Ferreiro S, Manrique Moral O, Garc\u00eda Romero R, Irastorza Terradillos I, Nu\u00f1ez Ramos R, et al. Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data. J Pediatr Gastroenterol Nutr. 2020 Dec;71(6):734\u20139.","DOI":"10.1097\/MPG.0000000000002899"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Chen K, Mu F, Xie J, Kelkar SS, Olivier C, Signorovitch J, et al. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure. JPEN J Parenter Enteral Nutr. 2020 Jan;44(1):119\u201328.","DOI":"10.1002\/jpen.1588"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Jeppesen PB, Pertkiewicz M, Forbes A, Pironi L, Gabe SM, Joly F, et al . Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study. Clin Nutr. 2013 Oct;32(5):713-21.","DOI":"10.1016\/j.clnu.2013.03.016"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Martin A, Boehm V, Zappa M, Billiauws L, Bonvalet F, Nuzzo A, et al. Imaging as predictor of clinical response to teduglutide in adult patients with short bowel syndrome with chronic intestinal failure. Am J Clin Nutr. 2021 May 8;113(5):1343\u201350.","DOI":"10.1093\/ajcn\/nqaa412"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Fujioka K, Jeejeebhoy K, Pape UF, Li B, Youssef NN, Schneider SM. Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide. JPEN J Parenter Enteral Nutr. 2017 Nov;41(8):1419-1422.","DOI":"10.1177\/0148607116663481"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Harpain F, Schlager L, H\u00fctterer E, Dawoud C, Kirchnawy S, Stift J, Krotka P, Stift A MD. Teduglutide in short bowel syndrome patients: A way back to normal life? J Parenter Enteral Nutr. 2022;46:300-309","DOI":"10.1002\/jpen.2272"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Ukleja A MD, To C MD, \u00c1lvarez A MD, Lara LF MD. Long-Term Therapy With Teduglutide in perenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series. J Parenter Enteral Nutr. 2018;42:821-825","DOI":"10.1002\/jpen.1149"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Jeppesen PB, Shahraz S, Hopkins T, Worsfold A, Genestin E. Impact of intestinal failure and parenteral support on adult patients with short-bowel syndrome: A multinational, noninterventional, cross-sectional survey. JPEN J Parenter Enteral Nutr. 2022 Sep;46(7):1650-1659.","DOI":"10.1002\/jpen.2372"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"P. Bergh\u00f6ferK.C. FragkosJ.P. BaxterA. ForbesF. JolyH. HeinzeS. LothM. PertkiewiczB. MessingP.B. Jeppesen12. Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL) scale. Clin Nutr. 32 (2013) 789-796.","DOI":"10.1016\/j.clnu.2012.12.001"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Pironi L. Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short-Bowel Syndrome: A Review of Recent Literature. JPEN J Parenter Enteral Nutr. 2020 Aug;44(6):968-978.","DOI":"10.1002\/jpen.1757"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Sowerbutts AM, Burden S, Griffiths J, Abraham A, Farrer K, Leahy G, et al. Glucagon-like peptide 2 analogues in the treatment of intestinal failure: A qualitative exploration of the views of patients and their families in decision making. Clin Nutr. ESPEN. 2021 Aug;44:263-269.","DOI":"10.1016\/j.clnesp.2021.06.005"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Cuerda C, Pironi L, Arends J, Bozzetti F, Gillanders L, Jeppesen PB, et al . Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of ESPEN. ESPEN practical guideline: Clinical nutrition in chronic intestinal failure. Clin Nutr. 2021 Sep;40(9):5196-5220.","DOI":"10.1016\/j.clnu.2021.07.002"}],"container-title":["Nutrici\u00f3n Hospitalaria"],"original-title":[],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T11:36:06Z","timestamp":1687347366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nutricionhospitalaria.org\/articles\/04646\/show"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":31,"URL":"https:\/\/doi.org\/10.20960\/nh.04646","relation":{},"ISSN":["1699-5198","0212-1611"],"issn-type":[{"value":"1699-5198","type":"electronic"},{"value":"0212-1611","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}